Monday, September 14, 2026
Home Authors Posts by Ogkologos

Ogkologos

4337 POSTS 0 COMMENTS

No Additional Benefit From Tiragolumab Plus Atezolizumab Over Durvalumab in Locally...

Ogkologos -
0

EMA Recommends Extension of Indications for Datopotamab Deruxtecan

Ogkologos -
0

High-Dose Chemotherapy Followed by ASCT Improves Survival Compared with Non-myeloablative Consolidation...

Ogkologos -
0

ESMO Clinical Practice Guideline Express Update on daraxonrasib in the treatment...

Ogkologos -
0

FDA Approves Isatuximab-irfc for Subcutaneous Injection for Multiple Myeloma Indications

Ogkologos -
0

Belzutifan Plus Lenvatinib Improves Outcomes Over Cabozantinib in Patients with Advanced...

Ogkologos -
0

Combining 177Lu-PSMA-617 with ADT Plus ARPI Prolongs rPFS in Patients with...

Ogkologos -
0

EMA Recommends Extension of Therapeutic Indications for Cetuximab

Ogkologos -
0

No OS Benefit from Continuous as Compared with Fixed-Duration Maintenance Therapy...

Ogkologos -
0

FDA Approves Allogeneic Regulatory T Cell-Based Immunotherapy with HSPC and T...

Ogkologos -
0
1234...434Page 3 of 434

MOST POPULAR

Load more

HOT NEWS

Follow us on Instagram @ogkologos

Το πρώτο ολοκληρωμένο portal για τον καρκίνο. Ενημερωθείτε για τον καρκίνο, καθώς και για τις τελευταίες εξελίξεις.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2023 Ogkologos.com